Achilles Therapeutics’s raising of $120 million to conduct clinical trials of a cancer treatment underscores the promise of therapies that use immune systems to target and eradicate tumor cells. The Achilles therapy uses a unique T-cell, a type of white blood cell integral to the body’s immune system to target and eliminate abnormal cancer cells, […]

Know more, do more.

You'll get access to all of our original analysis, exclusive features, and more for just $9.